Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming

The majority of breast cancers expresses the estrogen receptor (ER(+)) and is treated with anti-estrogen therapies, particularly tamoxifen in premenopausal women. However, tamoxifen resistance is responsible for a large proportion of breast cancer deaths. Using small molecule inhibitors, phospho-mim...

Descripción completa

Detalles Bibliográficos
Autores principales: Geter, Phillip A., Ernlund, Amanda W., Bakogianni, Sofia, Alard, Amandine, Arju, Rezina, Giashuddin, Shah, Gadi, Abhilash, Bromberg, Jacqueline, Schneider, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769768/
https://www.ncbi.nlm.nih.gov/pubmed/29269484
http://dx.doi.org/10.1101/gad.305631.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769768/
https://www.ncbi.nlm.nih.gov/pubmed/29269484
http://dx.doi.org/10.1101/gad.305631.117

Ejemplares similares